BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 18076787)

  • 1. [Role of Rho GTPase in inhibiting metastatic ability of human prostate cancer cell line PC-3 by omega-3 polyunsaturated fatty acid].
    Yi L; Zhang QY; Mi MT
    Ai Zheng; 2007 Dec; 26(12):1281-6. PubMed ID: 18076787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth.
    Pandalai PK; Pilat MJ; Yamazaki K; Naik H; Pienta KJ
    Anticancer Res; 1996; 16(2):815-20. PubMed ID: 8687134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.
    Narayanan NK; Narayanan BA; Reddy BS
    Int J Oncol; 2005 Mar; 26(3):785-92. PubMed ID: 15703837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of low-dose docosahexaenoic acid and eicosapentaenoic acid on the regulation of mitogenic signaling pathways in mesangial cells.
    Yusufi AN; Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Grande JP
    J Lab Clin Med; 2003 May; 141(5):318-29. PubMed ID: 12761475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells.
    Schley PD; Jijon HB; Robinson LE; Field CJ
    Breast Cancer Res Treat; 2005 Jul; 92(2):187-95. PubMed ID: 15986129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells.
    Altenburg JD; Siddiqui RA
    Mol Cancer Res; 2009 Jul; 7(7):1013-20. PubMed ID: 19567784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase.
    Zhou C; Ling MT; Kin-Wah Lee T; Man K; Wang X; Wong YC
    Cancer Lett; 2006 Feb; 233(1):36-47. PubMed ID: 16473668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier.
    Pifferi F; Jouin M; Alessandri JM; Haedke U; Roux F; Perrière N; Denis I; Lavialle M; Guesnet P
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):279-86. PubMed ID: 18042368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overexpression of human tumor metastasis-related gene TMSG-1 suppresses cell proliferation and invasion of a highly metastatic prostate cancer cell line PC-3M-1E8 in vitro].
    Su J; You JF; Wang JL; Cui XL; Fang WG; Zheng J
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):404-7. PubMed ID: 19024511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-3 but not N-6 fatty acids reduce the expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells.
    Pietsch A; Weber C; Goretzki M; Weber PC; Lorenz RL
    Cell Biochem Funct; 1995 Sep; 13(3):211-6. PubMed ID: 7554100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells.
    Siddiqui RA; Zerouga M; Wu M; Castillo A; Harvey K; Zaloga GP; Stillwell W
    Breast Cancer Res; 2005; 7(5):R645-54. PubMed ID: 16168109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marine phosphatidylcholine suppresses 1,2-dimethylhydrazine-induced colon carcinogenesis in rats by inducing apoptosis.
    Fukunaga K; Hossain Z; Takahashi K
    Nutr Res; 2008 Sep; 28(9):635-40. PubMed ID: 19083470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and invasiveness in MDA-MB-231 breast cancer cells.
    Horia E; Watkins BA
    Carcinogenesis; 2007 Apr; 28(4):809-15. PubMed ID: 17052999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apoptosis of human gastric cancer cells induced by omega-3 polyunsaturated fatty acids].
    Yin Y; Zhan WH; Peng JS; Zhao ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Nov; 10(6):570-3. PubMed ID: 18000782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase-C gamma-1 (PLCgamma-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells.
    Davies G; Martin TA; Ye L; Lewis-Russell JM; Mason MD; Jiang WG
    Urol Oncol; 2008; 26(4):386-91. PubMed ID: 18367108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of cantharidin on invasion and metastasis of highly metastatic ovarian carcinoma cell line HO-8910PM].
    He TP; Mo LE; Liang NC
    Ai Zheng; 2005 Apr; 24(4):443-7. PubMed ID: 15820067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
    Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
    Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
    Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
    Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status.
    Kato T; Kolenic N; Pardini RS
    Nutr Cancer; 2007; 58(2):178-87. PubMed ID: 17640164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical-physical changes in cell membrane microdomains of breast cancer cells after omega-3 PUFA incorporation.
    Corsetto PA; Cremona A; Montorfano G; Jovenitti IE; Orsini F; Arosio P; Rizzo AM
    Cell Biochem Biophys; 2012 Sep; 64(1):45-59. PubMed ID: 22622660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.